| Disease Info Index | ||||||||||||||||||||||||||
|
|
|
|
|
Text
|
2011 Dec 1 Health-Related Quality of Life and Treatment Satisfaction in the Sensor-Augmented Pump Therapy for A1C Reduction 3 (STAR 3) Trial. Rubin RR, Peyrot M 1 Department of Medicine, The Johns Hopkins University School of Medicine , Baltimore, Maryland. Abstract Objective: This study assessed health-related quality of life (HRQOL) and treatment satisfaction in sensor-augmented pump therapy (SAPT) co... Read More Source: PubMed Vojnosanit Pregl Short-term use of continuous glucose monitoring system adds to glycemic control in young type 1 diabetes mellitus patients in the long run: a clinical trial. Bukara-Radujkovic G, Zdravkovic D, Lakic S Children's Hospital, Department for Endocrinology, Banja Luka, Bosnia and Herzegovina. gocabr@inecco.net BACKGROUND/AIM: Balancing strict glycemic control with setting realistic goals for each individual child and family can optimize growth, ensure normal... Read More Source: PubMed 2011 Nov 21 Perceptions of Caribbean type 2 diabetes patients on self-monitoring of blood glucose. Ezenwaka CE, Olukoga A, Onuoha P, Worrell R, Skinner T, Mayers H, Martin E, Phillip C The Diabetes & Metabolism Research Group, Faculty of Medical Sciences, The University of the West Indies , St Augustine Campus , Trinidad. Context: The views of type 2 diabetes (T2DM) patients have not been considered in the debate on the role of self-monitoring of blood glucose (SMBG) in... Read More Source: PubMed 2011 Nov 18 Short- and Long-Term Effects of Real-Time Continuous Glucose Monitoring in Patients With Type 2 Diabetes. Vigersky RA, Fonda SJ, Chellappa M, Walker MS, Ehrhardt NM Diabetes Institute, Department of Endocrinology and Metabolism, Walter Reed National Military Medical Center, Bethesda, Maryland. OBJECTIVETo determine whether short-time, real-time continuous glucose monitoring (RT-CGM) has long-term salutary glycemic effects in patients with ty... Read More Source: PubMed Int. J. Clin. Pract. Diabetes technology and the human factor. Liberman A, Buckingham B, Phillip M Schneider Children's Medical Center of Israel, Petah Tikva, Israel. mosheph@post.tau.ac.il When developing new technologies for human use the developer should take into consideration not only the efficacy and safety of the technology but als... Read More Source: PubMed Int. J. Clin. Pract. Diabetes technology and treatments in the paediatric age group. Shalitin S, Peter Chase H Institute of Endocrinology and Diabetes, Schneider Children's Medical Center of Israel. shalitin@netvision.net.il Type 1 diabetes (T1D) is one of the most common chronic childhood diseases and its incidence has doubled during the last decade. The goals of intensiv... Read More Source: PubMed Int. J. Clin. Pract. Self-monitoring of blood glucose. Garg SK, Hirsch IB University of Colorado Health Science Center, Aurora, CO, USA. satish.garg@ucdenver.edu Many would argue that the introduction of modern-day diabetes management started 30 years ago with the introduction of self-monitoring of blood glucos... Read More Source: PubMed 2011 Nov 2 A Comparison of Average Daily Risk Range Scores for Young Children with Type 1 Diabetes Mellitus Using Continuous Glucose Monitoring and Self-Monitoring Data. Patton SR, Midyett LK, Dolan LM, Powers SW 1 Department of Pediatrics, University of Kansas Medical Center , Kansas City, Kansas. Abstract Background: Young children with type 1 diabetes are vulnerable to glycemic excursion. Continuous glucose monitoring (CGM), combined with va... Read More Source: PubMed Pol. Arch. Med. Wewn. Efficacy and safety comparison of continuous glucose monitoring and self-monitoring of blood glucose in type 1 diabetes: systematic review and meta-analysis. Wojciechowski P, Rys P, Lipowska A, Gaweska M, Malecki MT Self-monitoring of blood glucose (SMBG) is a crucial element of clinical care in type 1 diabetes, but it may not provide adequate glucose control. A n... Read More Source: PubMed 2011 Oct 20 Telecare Provides Comparable Efficacy to Conventional Self-Monitored Blood Glucose in Patients with Type 2 Diabetes Titrating One Injection of Insulin Glulisine-the ELEONOR Study. Prato SD, Nicolucci A, Lovagnini-Scher AC, Turco S, Leotta S, Vespasiani On Behalf Of The Eleonor Study Group G 1 Department of Endocrinology and Metabolism, University of Pisa , Pisa, Italy . Abstract Background: We compared telecare and conventional self-monitored blood glucose (SMBG) programs for titrating the addition of one bolus inje... Read More Source: PubMed Vojnosanit Pregl Short-term use of continuous glucose monitoring system adds to glycemic control in young type 1 diabetes mellitus patients in the long run: a clinical trial. Bukara-Radujkovic G, Zdravkovic D, Lakic S Children's Hospital, Department for Endocrinology, Banja Luka, Bosnia and Herzegovina. gocabr@inecco.net BACKGROUND/AIM: Balancing strict glycemic control with setting realistic goals for each individual child and family can optimize growth, ensure normal... Read More Source: PubMed 2011 Dec 1 Health-Related Quality of Life and Treatment Satisfaction in the Sensor-Augmented Pump Therapy for A1C Reduction 3 (STAR 3) Trial. Rubin RR, Peyrot M 1 Department of Medicine, The Johns Hopkins University School of Medicine , Baltimore, Maryland. Abstract Objective: This study assessed health-related quality of life (HRQOL) and treatment satisfaction in sensor-augmented pump therapy (SAPT) co... Read More Source: PubMed 2011 Nov 21 Perceptions of Caribbean type 2 diabetes patients on self-monitoring of blood glucose. Ezenwaka CE, Olukoga A, Onuoha P, Worrell R, Skinner T, Mayers H, Martin E, Phillip C The Diabetes & Metabolism Research Group, Faculty of Medical Sciences, The University of the West Indies , St Augustine Campus , Trinidad. Context: The views of type 2 diabetes (T2DM) patients have not been considered in the debate on the role of self-monitoring of blood glucose (SMBG) in... Read More Source: PubMed 2011 Nov 18 Short- and Long-Term Effects of Real-Time Continuous Glucose Monitoring in Patients With Type 2 Diabetes. Vigersky RA, Fonda SJ, Chellappa M, Walker MS, Ehrhardt NM Diabetes Institute, Department of Endocrinology and Metabolism, Walter Reed National Military Medical Center, Bethesda, Maryland. OBJECTIVETo determine whether short-time, real-time continuous glucose monitoring (RT-CGM) has long-term salutary glycemic effects in patients with ty... Read More Source: PubMed Int. J. Clin. Pract. Diabetes technology and the human factor. Liberman A, Buckingham B, Phillip M Schneider Children's Medical Center of Israel, Petah Tikva, Israel. mosheph@post.tau.ac.il When developing new technologies for human use the developer should take into consideration not only the efficacy and safety of the technology but als... Read More Source: PubMed Int. J. Clin. Pract. Diabetes technology and treatments in the paediatric age group. Shalitin S, Peter Chase H Institute of Endocrinology and Diabetes, Schneider Children's Medical Center of Israel. shalitin@netvision.net.il Type 1 diabetes (T1D) is one of the most common chronic childhood diseases and its incidence has doubled during the last decade. The goals of intensiv... Read More Source: PubMed Int. J. Clin. Pract. Self-monitoring of blood glucose. Garg SK, Hirsch IB University of Colorado Health Science Center, Aurora, CO, USA. satish.garg@ucdenver.edu Many would argue that the introduction of modern-day diabetes management started 30 years ago with the introduction of self-monitoring of blood glucos... Read More Source: PubMed 2011 Nov 2 A Comparison of Average Daily Risk Range Scores for Young Children with Type 1 Diabetes Mellitus Using Continuous Glucose Monitoring and Self-Monitoring Data. Patton SR, Midyett LK, Dolan LM, Powers SW 1 Department of Pediatrics, University of Kansas Medical Center , Kansas City, Kansas. Abstract Background: Young children with type 1 diabetes are vulnerable to glycemic excursion. Continuous glucose monitoring (CGM), combined with va... Read More Source: PubMed Pol. Arch. Med. Wewn. Efficacy and safety comparison of continuous glucose monitoring and self-monitoring of blood glucose in type 1 diabetes: systematic review and meta-analysis. Wojciechowski P, Rys P, Lipowska A, Gaweska M, Malecki MT Self-monitoring of blood glucose (SMBG) is a crucial element of clinical care in type 1 diabetes, but it may not provide adequate glucose control. A n... Read More Source: PubMed 2011 Oct 20 Telecare Provides Comparable Efficacy to Conventional Self-Monitored Blood Glucose in Patients with Type 2 Diabetes Titrating One Injection of Insulin Glulisine-the ELEONOR Study. Prato SD, Nicolucci A, Lovagnini-Scher AC, Turco S, Leotta S, Vespasiani On Behalf Of The Eleonor Study Group G 1 Department of Endocrinology and Metabolism, University of Pisa , Pisa, Italy . Abstract Background: We compared telecare and conventional self-monitored blood glucose (SMBG) programs for titrating the addition of one bolus inje... Read More Source: PubMed |
| Share it! |
|
|
|
|




|
Posted by:
rjames
Posted on: 05/11/2012 after lunch I often work in the yard for l to 2 hrs and take my test when I come in. Does moving around after a meal increase the sugar in my blood more than sitting for the 2 hours?
Reply |
Forward
Posted by:
mouna(Guest)
Posted on: 05/17/2012 any physical activity you perform will contribute to lowering your blood sugar level.
Reply |
Forward
|
|
Posted by:
michelledale(Guest)
Posted on: 02/12/2010 Can anyone please tell me what are the normal sugar levels in a type 2 diabetes, as my husband and I are having problems monitoring him. |
|
|
| Citing this Health Article | ||||||
|
||||||
| News on Diabetes - Self-Monitoring of Blood Glucose (SMBG) |
|
Women With Gestational Diabetes Have Better Outcomes Via Phone Contact With Nurses |
|
Severity of Sleep Apnea Could Predict Diabetes |
|
Proper Care Can Prevent Amputations in Diabetic Foot Infections |
|
ACE2, Protective Molecule Champions in Diabetic Patients |
|
Bariatric Surgery can Lower Blood Sugar Levels |
| Total News Item 1522 | |